Botulinum Toxin Injections
J15
53 active Medicare policies list G43.401, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
5 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of G43.401 |
|---|---|---|
| Genetic Testing | Feb 27, 2024 | Covered |
| Headaches: Nonsurgical Management | Feb 16, 2024 | Covered |
| Policy | Effective | Status of G43.401 |
|---|---|---|
| Visual Field Testing | Not recorded | Covered |
| Policy | Effective | Status of G43.401 |
|---|---|---|
| Peripheral Nerve Destruction for Pain Conditions |
J5
J8 · Effective Feb 22, 2026
J15 · Effective Nov 2, 2020
J6 · Effective Nov 1, 2020
JK · Effective Nov 1, 2020
JE · Effective Dec 13, 2020
JF · Effective Dec 13, 2020
JJ · Effective Feb 7, 2021
JM · Effective Feb 7, 2021
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
J6 · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Oct 1, 2025
National · Effective Jan 1, 2026
National · Effective Oct 1, 2025
JL · Effective Oct 1, 2025
National · Effective Oct 23, 2025
National · Effective Oct 1, 2025
National · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
J5 · Effective Oct 1, 2025
| Sep 15, 2026 |
| Not covered |
| Policy | Effective | Status of G43.401 |
|---|---|---|
| Vyepti (Eptinezumab-Jjmr) | Sep 1, 2026 | Covered |